EMVO would like to inform you that a new version of the European Commission’s Questions & Answers document on “Safety Features for Medicinal Products for Human Use (V.17)” is now available (changes highlighted for your convenience). Please kindly note that the changes include the addition of a new Q&A (5.11) and the revision of Q&A 1.22.

This document was published by the European Commission.